3-Chloro-2-[(1E)-(2,4-dichlorophenyl)(2-phenylhydrazin-1-ylidene)methyl]-5-(trifluoromethyl)pyridine

Catalog No. :
ACNMTI912
CAS No. :
306977-42-4
Molecular Formula :
C19H11Cl3F3N3
Molecular Weight :
444.67

IUPAC Name:(E)-3-chloro-2-((2,4-dichlorophenyl)(2-phenylhydrazineylidene)methyl)-5-(trifluoromethyl)pyridine

3-Chloro-2-[(1E)-(2,4-dichlorophenyl)(2-phenylhydrazin-1-ylidene)methyl]-5-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Chloro-2-[(1E)-(2,4-dichlorophenyl)(2-phenylhydrazin-1-ylidene)methyl]-5-(trifluoromethyl)pyridine
IUPAC Name(E)-3-chloro-2-((2,4-dichlorophenyl)(2-phenylhydrazineylidene)methyl)-5-(trifluoromethyl)pyridine
Molecular FormulaC19H11Cl3F3N3
Molecular Weight444.67
SMILESFC(C1=CN=C(/C(C2=CC=C(Cl)C=C2Cl)=N/NC3=CC=CC=C3)C(Cl)=C1)(F)F
InChI KeyRWSNZPOZOSGWPK-OGLMXYFKSA-N
Synonym[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL](2,4-DICHLOROPHENYL)METHANONE N-PHENYLHYDRAZONE;3-chloro-2-[(1E)-(2,4-dichlorophenyl)(2-phenylhydrazin-1-ylidene)methyl]-5-(trifluoromethyl)pyridine;Methanone, [3-chloro-5-(trifluoromethyl)-2-pyridinyl](2,4-dichlorophenyl)-, 2-phenylhydrazone
CAS No.306977-42-4

Synthetic Route by SureRoute

1. ACNMTI912 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNMTI912 route product structure diagram
    ACNMTI912306977-42-4
Inquiry

2. ACNMTI912 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNMTI912 route product structure diagram
    ACNMTI912306977-42-4
Inquiry

Comments (0)